Z-1322-2015 Class II Terminated

Recalled by Ossur H / F — Reykjavik

FDA device recall Z-1322-2015 was initiated by Ossur H / F on Feb 26, 2015 and is designated Class II. Reason for recall: The firm is recalling Rheo Knee bionic prosthetic due to it being discovered during an internal audit of the service line that devices were released for distribution without fully going through the… The recall status is terminated (terminated Nov 20, 2015). Affected quantity: 4715 units (2 units affected).

Recall details

Product Type
Devices
Report Date
Apr 1, 2015
Initiation Date
Feb 26, 2015
Termination Date
Nov 20, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4715 units (2 units affected)

Product description

The Rheo Knee bionic prosthetic is to be used exclusively for fittings of lower extremity amputations. RHEO KNEE uses Artificial Intelligence to continuously adapt to the users walking style and environment. The RHEO KNEE recognizes and responds immediately to changes in speed, load and terrain, restoring the users ability to walk naturally, comfortably and confidently at any speed.

Reason for recall

The firm is recalling Rheo Knee bionic prosthetic due to it being discovered during an internal audit of the service line that devices were released for distribution without fully going through the assembly process.

Distribution pattern

Worldwide distribution: US distribution in TN and country of: Austria.

Code information

Rheo 2 Item Number: RKN120007 Serial #s affected: 323056 321498

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1322-2015
openFDA file date
Nov 17, 2026
Loaded by RegDataLab
Nov 18, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1322-2015. Report a data issue: hello@regdatalab.com.